These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 14968327)

  • 1. [Treatment of scalp psoriasis. An effective and safe tacalcitol emulsion].
    Ruzicka T; Trompke C
    Hautarzt; 2004 Feb; 55(2):165-70. PubMed ID: 14968327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis.
    van de Kerkhof PC; Berth-Jones J; Griffiths CE; Harrison PV; Hönigsmann H; Marks R; Roelandts R; Schöpf E; Trompke C
    Br J Dermatol; 2002 Mar; 146(3):414-22. PubMed ID: 11952541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience.
    Lecha M; Mirada A; López S; Artés M;
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):414-7. PubMed ID: 15987284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial.
    Veien NK; Bjerke JR; Rossmann-Ringdahl I; Jakobsen HB
    Br J Dermatol; 1997 Oct; 137(4):581-6. PubMed ID: 9390335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety.
    Van de Kerkhof PC; Werfel T; Haustein UF; Luger T; Czarnetzki BM; Niemann R; Plänitz-Stenzel V
    Br J Dermatol; 1996 Nov; 135(5):758-65. PubMed ID: 8977677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris.
    Miyachi Y; Ohkawara A; Ohkido M; Harada S; Tamaki K; Nakagawa H; Hori Y; Nishiyama S
    Eur J Dermatol; 2002; 12(5):463-8. PubMed ID: 12370136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: an open, multicentre, randomized, controlled, cross-over study on 241 patients.
    Andreassi L; Giannetti A; Milani M;
    Br J Dermatol; 2003 Jan; 148(1):134-8. PubMed ID: 12534607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacalcitol ointment for long-term control of chronic plaque psoriasis in dermatological practice.
    Lambert J; Trompke C
    Dermatology; 2002; 204(4):321-4. PubMed ID: 12077538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, randomized, double-blind study of the efficacy and safety of calcipotriene foam, 0.005%, vs vehicle foam in the treatment of plaque-type psoriasis of the scalp.
    Feldman SR; Mills M; Brundage T; Eastman WJ
    J Drugs Dermatol; 2013 Mar; 12(3):300-6. PubMed ID: 23545912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of efficacy and safety of calcipotriol versus tacalcitol ointment, both in combination with NBUVB phototherapy in the treatment of stable plaque psoriasis.
    Dua I; Aggarwal K; Jain VK
    Photodermatol Photoimmunol Photomed; 2017 Sep; 33(5):275-281. PubMed ID: 28602032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas.
    Ortonne JP; Humbert P; Nicolas JF; Tsankov N; Tonev SD; Janin A; Czernielewski J; Lahfa M; Dubertret L
    Br J Dermatol; 2003 Feb; 148(2):326-33. PubMed ID: 12588387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four cases of sebopsoriasis or seborrheic dermatitis of the face and scalp successfully treated with 1a-24 (R)-dihydroxycholecalciferol (tacalcitol) cream.
    Nakayama J
    Eur J Dermatol; 2000; 10(7):528-32. PubMed ID: 11056423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of clinical efficacy and safety of topical tacalcitol.
    Leone G; Pacifico A
    Acta Biomed; 2005 Apr; 76(1):13-9. PubMed ID: 16116820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-concentration (20 mug/g) tacalcitol ointment therapy on refractory psoriasis vulgaris with low response to topical corticosteroids.
    Katayama I; Ohkawara A; Ohkido M; Harada S; Tamaki K; Nakagawa H; Hori Y; Nishiyama S
    Eur J Dermatol; 2002; 12(6):553-7. PubMed ID: 12459526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of calcipotriol (MC903) solution and placebo (vehicle of MC903) in the treatment of psoriasis of the scalp.
    Green C; Ganpule M; Harris D; Kavanagh G; Kennedy C; Mallett R; Rustin M; Downes N
    Br J Dermatol; 1994 Apr; 130(4):483-7. PubMed ID: 8186114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placebo-controlled evaluation of the irritant potential of tacalcitol (1a,24-dihydroxyvitamin D3) in healthy volunteers.
    Schlotmann K; Ortland C; Neumann NJ; Ruzicka T; Lehmann P
    Contact Dermatitis; 2000 May; 42(5):260-3. PubMed ID: 10789839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical becocalcidiol for the treatment of psoriasis vulgaris: a randomized, placebo-controlled, double-blind, multicentre study.
    Helfrich YR; Kang S; Hamilton TA; Voorhees JJ
    Br J Dermatol; 2007 Aug; 157(2):369-74. PubMed ID: 17596167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive evaluation of tacalcitol plus puva versus tacalcitol plus UVB-NB in the treatment of psoriasis: "right-left intra-individual pre/post comparison design".
    Brazzelli V; Barbagallo T; Prestinari F; Rona C; De Silvestri A; Trevisan V; Borroni G
    Int J Immunopathol Pharmacol; 2005; 18(4):755-60. PubMed ID: 16388725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of calcipotriene plus betamethasone dipropionate topical suspension in the treatment of extensive scalp psoriasis in adolescents ages 12 to 17 years.
    Eichenfield LF; Ganslandt C; Kurvits M; Schlessinger J
    Pediatr Dermatol; 2015; 32(1):28-35. PubMed ID: 25412565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of secukinumab on moderate-to-severe scalp psoriasis: Results of a 24-week, randomized, double-blind, placebo-controlled phase 3b study.
    Bagel J; Duffin KC; Moore A; Ferris LK; Siu K; Steadman J; Kianifard F; Nyirady J; Lebwohl M
    J Am Acad Dermatol; 2017 Oct; 77(4):667-674. PubMed ID: 28780364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.